GIANNINI, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 8.225
EU - Europa 4.424
AS - Asia 2.596
SA - Sud America 301
OC - Oceania 79
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.694
Nazione #
US - Stati Uniti d'America 8.158
RU - Federazione Russa 2.040
SG - Singapore 746
HK - Hong Kong 698
IE - Irlanda 526
CN - Cina 493
SE - Svezia 450
PL - Polonia 420
KR - Corea 278
BR - Brasile 249
IT - Italia 240
DE - Germania 188
UA - Ucraina 185
FI - Finlandia 154
TR - Turchia 104
GB - Regno Unito 103
IN - India 88
VN - Vietnam 80
AU - Australia 77
CA - Canada 41
CI - Costa d'Avorio 41
FR - Francia 36
AR - Argentina 23
BE - Belgio 17
NL - Olanda 17
BD - Bangladesh 16
JP - Giappone 15
MX - Messico 13
JO - Giordania 12
CH - Svizzera 11
IQ - Iraq 11
ID - Indonesia 10
CO - Colombia 9
EC - Ecuador 8
AE - Emirati Arabi Uniti 7
ES - Italia 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
CZ - Repubblica Ceca 5
LT - Lituania 5
MA - Marocco 5
SC - Seychelles 5
AZ - Azerbaigian 4
EU - Europa 4
MY - Malesia 4
RO - Romania 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
JM - Giamaica 3
KZ - Kazakistan 3
NO - Norvegia 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
VE - Venezuela 3
DK - Danimarca 2
GD - Grenada 2
GR - Grecia 2
IL - Israele 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
SN - Senegal 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
HN - Honduras 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 15.694
Città #
Santa Clara 2.242
Fairfield 674
Ashburn 583
Hong Kong 581
Chandler 542
Dublin 526
Singapore 440
Warsaw 418
Cambridge 311
Seattle 299
Woodbridge 289
Seoul 278
Jacksonville 264
Wilmington 255
Beijing 237
Houston 236
Buffalo 176
Ann Arbor 161
Princeton 136
Boardman 106
Los Angeles 105
Boston 100
Izmir 93
Altamura 91
Lawrence 80
Melbourne 76
Mumbai 69
The Dalles 65
Medford 62
Dallas 51
Hefei 48
Bremen 43
Abidjan 41
Shanghai 40
Munich 38
San Diego 37
Moscow 35
Falls Church 26
Ho Chi Minh City 26
Norwalk 25
Hanoi 21
Redondo Beach 21
Toronto 21
Florence 19
Paris 19
New York 18
Brussels 17
São Paulo 17
Andover 16
Washington 16
Hillsboro 15
Tokyo 15
Turku 15
Milan 14
Dearborn 13
Chicago 12
Auburn Hills 11
Bern 11
Kent 11
Atlanta 10
Brooklyn 10
Denver 9
Frankfurt am Main 8
London 8
Old Bridge 8
Porto Alegre 8
Salerno 8
West Jordan 8
Brasília 7
Frankfurt Am Main 7
Rio de Janeiro 7
Stockholm 7
Verona 7
Baghdad 6
Dong Ket 6
Tashkent 6
Amman 5
Belo Horizonte 5
Brno 5
Curitiba 5
Laurel 5
Mexico City 5
Newark 5
Phoenix 5
Poplar 5
Redmond 5
Saint Petersburg 5
San Francisco 5
San Mateo 5
Tianjin 5
Baku 4
Cluj-Napoca 4
Dhaka 4
Istanbul 4
Jakarta 4
Johannesburg 4
Kuala Lumpur 4
New Delhi 4
Rome 4
Yubileyny 4
Totale 10.447
Nome #
Hepatitis C Virus infection in the immunocompromised host: a complex scenario with variable clinical impact 311
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 299
HCV and lymphoproliferation 248
HCV Patients Psychopathology and Tryptophan Metabolism: Analysis of the Effects of Pegylated Interferon plus Ribavirin Treatment 224
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 198
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 193
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 182
Host genetic determinants in HCV-related mixed cryoglobulinemia 180
Host genetic determinants in HCV-related mixed cryoglobulinemia 171
Analysis of HCV persistence in patients with sustained virological response 167
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 167
Chronic hepatitis C and B-cell non-Hodgkin's lymphoma 164
Interferon and thymosin combination therapy in naive patients with chronic hepatitis C. Preliminary results 163
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 161
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 161
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 159
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 158
Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment 153
HBV and HCV chronic infection: Autoimmune manifestations and lymphoproliferation 152
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 151
T(14;18) translocation in chronic hepatitis C virus infection 150
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 150
Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia 150
Involvement of PI3K in HCV-related lymphoproliferative disorders 148
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients 147
Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection 147
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 146
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 145
Host genetic determinants in HCV-related mixed cryoglobulinemia 144
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab 143
Tryptophan/kynurenine pathway changes in HCV-infected patients: possible involvement in associated neuropsychiatry pathology 143
Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications 141
Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways 140
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways. 140
Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role 140
Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection. 139
HCV INFECTION OF PERIPHERAL AND LIVER MONONUCLEAR-CELLS - PATHOGENIC IMPLICATIONS 139
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 138
Applicazione della metodica PCR (polymerase chain reaction) ed altre tecniche di biologia molecolare allo studio dell'infezione da virus C dell'epatite. 138
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. 136
HCV infection in mixed cryoglobulinemia and B-cell non-Hodgkin’s lymphoma. 135
A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector 134
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 133
Hepatitis C virus core protein enhances B lymphocyte proliferation 132
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 131
Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis 128
Hepatitis C virus lymphotropism and possible pathogenetic implications 126
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 125
Tryptophan/Kynurenine pathway changes in HCV infected patients: possible involvment in associated neuropsychiathy pathology. 125
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 123
ANALYSIS OF HCV INFECTION IN PATIENTS WITH B-CELL NON-HODGKINS-LYMPHOMA 122
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 122
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 121
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 121
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 121
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 120
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 120
HCV infection and carotid atherosclerosis: evidence in favour of a local viral action inside the plaque 119
Lack of preferential localization of tumoral mass in B-cell non-Hodgkin's lymphoma associated with hepatitis C virus infection 118
Hepatitis C virus-related lymphoproliferative disorders: an overview 117
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 117
Effect of antiviral treatment on the prevalence of BCL-2 recombination in HCV infected patients 114
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 114
Serum HCV-RNA and liver histologic findings in patients with long-term normal transaminases 114
Tryptophan/kynurenine Patway Changes in HCV-infected Patients: Possible Involvement In Associated Neuropsychiatry Pathology 113
The Hepatitis C Virus Infection as a Systemic Disease 112
The role of the rs12979860 polymorphism of the interleukin-28b as predictor of spontaneus clearance of HCV infection in patients with hemophilia 112
Hepatitis C virus RNA localization in human carotid plaques. 112
Characterization of uptake, degradation and toxicity of antisense ODNs in cancer cells. Characterization of uptake, degradation and toxicity of antisense ODNs in cancer cells 110
Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesis 110
Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis 109
Effects of depletion of B cell by anti-CD20 monoclonal antibody in HCV+ mixed cryoglobulinemia (MC) and liver cirrhosis 109
Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes 108
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 107
Hepatitis C virus biology. 106
Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases 106
Mixed cryoglobulinemia syndrome is a negative prognostic factor in the standard of care (Peg-IFN+ribavirin) anti-HCV therapy 105
Is t(14;18)(q32;q21) translocation a hallmark of HCV-related mixed cryoglobulinemia? 105
Can depletion of B-cells by anti-CD20 monoclonal antibody in HCV plus mixed cryoglobulinemia (MC) improve liver cirrhosis? 104
Eventi Oncomolecolari nella Crioglobulinemia Mista 104
Is T(14;18)(q32;q21) translocation a hallmark of HCV-related mixed cryoglobulinemia? 103
E' possibile la trasmissione del virus C dell'epatite nei centri di dialisi mediante il passaggio attraverso la membrana emodialitica? Risultati di uno studio preliminare 103
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 102
Hepatitis C virus as a lymphotropic agent: Evidence and pathogenetic implications 102
Could HGV infection be implicated in lymphomagenesis? 100
HCV infection in B-cell non-Hodgkin’s lymphoma. 99
Hepatotropic viruses: new insights in pathogenesis and treatment 98
HCV infection of mononuclear cells in chronic hepatitis and in mixed cryoglobulinaemia: possible pathogenetic implications. 98
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 98
Association between HCV infection and monoclonal gammopathy (MG): A putative role for genotype 2a? 97
Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx 96
Gene modulation associated with inhibition of liver regeneration in hepatitis B virus X transgenic mice. 96
HCV core protein induces B lymphocytes proliferation increasing DNP63 expression 96
HCV infection in B-cell non-Hodgkin's lymphoma 96
Hepatitis C virus lymphotrophism: lesson from a decade of studies 95
HCV infection in B-cell non-Hodgkin's lymphoma 94
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. 92
Reply: HCV infection and psychopathological disorders 91
Effect of rituximab on advanced liver disease in patients with HCV-related mixed cryoglobulinemia. 91
Il virus dell'epatite C (HCV): l'infezione e la malattia 88
Totale 13.245
Categoria #
all - tutte 42.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.465


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021515 0 0 0 0 0 126 16 72 74 103 68 56
2021/2022879 6 122 21 43 29 18 24 54 35 12 198 317
2022/20232.211 224 230 99 184 230 459 325 103 244 22 59 32
2023/2024658 43 99 145 41 50 83 17 132 7 11 12 18
2024/20255.735 166 591 364 834 2.065 608 74 383 267 94 163 126
2025/20262.425 643 710 309 205 521 37 0 0 0 0 0 0
Totale 15.707